NCT01809353View on ClinicalTrials.gov

To Assess the Pharmacokinetics and Safety of Single Doses of JNJ-54452840 in Healthy Japanese and Caucasian Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

Healthy

Interventions

DRUG

JNJ-54452840

Single intravenous (medication is injected into a vein) doses of 20 mg, 80 mg, and 240 mg

OTHER

Placebo

Single matching intravenous dose

Trial Locations (1)

Unknown

Cypress

All Listed Sponsors

lead

Janssen Research & Development, LLC

INDUSTRY

NCT01809353 - To Assess the Pharmacokinetics and Safety of Single Doses of JNJ-54452840 in Healthy Japanese and Caucasian Participants | Biotech Hunter | Biotech Hunter